Company News

News Report on Asian Regional Drug Development Summit 2014

Time: 2014/3/12 15:05:20      Views: 817

Deliver Life Sciences is pleased to bring the inaugural Asian Regional Drug Development Summit 2014 has been successfully convened at InterContinental Shanghai Pudong Hotel at Feb.18-20. 2014 under the support from Society for Clinical Trials and SAPA-GP. ARDDS 2014 also serves as the progressive platform to communicate and exchange views for the 'Efficient' and 'GCP-Compliant' Clinical Research in Asia and had invited over 50 Speakers from Regulatory Agencies, Association, Industry and Academia.

Selected Presentations

Early Drug Development in Asia - Opportunities and Challenges

Alexandre LeBeaut, Senior Vice President, Global Drug Development, Ipsen Pharmaceuticals


Japan's Evolving Role in Pan-Asian Regulatory and Development Strategy

John Winebarger, CEO, Integrated Development Associates


The Role and Importance of Asia in Global Pharmaceutical Product Development

- Opportunities for Innovation 

Barbara E. Tardiff, Vice President, Worldwide Head of Clinical Informatics and Innovation, Pfizer

Strategy for Japan and Asia on clinical data quality - viewpoints of the trial site

Toshiyoshi Tominaga, Professor and Director, Center for Drug and Food Clinical Evaluation,

Osaka City University Hospital


New wave of drug develop in Japan- How to harmonize and secure the synergistic effect of

Pan-Asian trials in Asia's complex clinical and regulatory framework

Hiroshi Sugii, Vice President, CMR Development Division, Novo Nordisk Japan


Can e-Clinical Innovations help Asia Drug Development Leapfrog?

Frank Shen, Vice President, Data and Statistical Sciences, Global Pharmaceutical R&D, Abbvie


Quality Management Approaches to Identification of Reducing Risks in Global Clinical Trials

Nancy Meyerson-Hess, Global Compound Development Quality Management, GCD-CDO-QM

Grunenthal GmbH


Meeting the Challenges of Safety Monitoring in Asia

Rebecca Wang, Executive Medical Director, Global Regulatory Affairs and Safety, 

Bone Safety TA Head, Amgen


For more information about the conference proceedings and presentation manuscripts, 

please forward your enquiry to